Fidelity Investments’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.8M	Sell	1,024,304 -275,792	-21%	-$5.27M	﹤0.01%	1850
2025 Q4	$20.4M	Sell	1,300,096 -1,512,155	-54%	-$20.4M	﹤0.01%	1765
2025 Q3	$20.8M	Buy	2,812,251 +524,217	+23%	+$2.78M	﹤0.01%	1742
2025 Q2	$10.3M	Sell	2,288,034 -2,386,074	-51%	-$10.6M	﹤0.01%	1918
2025 Q1	$21.7M	Sell	4,674,108 -874,340	-16%	-$5.36M	﹤0.01%	1649
2024 Q4	$38.5M	Buy	5,548,448 +447,035	+9%	+$3.35M	﹤0.01%	1487
2024 Q3	$27M	Buy	5,101,413 +6,439	+0.1%	+$32.5K	﹤0.01%	1610
2024 Q2	$19.1M	Sell	5,094,974 -245,828	-5%	-$1.25M	﹤0.01%	1670
2024 Q1	$37.7M	Sell	5,340,802 -196,437	-4%	-$1.17M	﹤0.01%	1424
2023 Q4	$31.3M	Sell	5,537,239 -467,594	-8%	-$1.83M	﹤0.01%	1468
2023 Q3	$28.8M	Sell	6,004,833 -540,899	-8%	-$3.48M	﹤0.01%	1458
2023 Q2	$44.8M	Buy	6,545,732 +124,693	+2%	+$806K	﹤0.01%	1318
2023 Q1	$50M	Buy	6,421,039 +203,581	+3%	+$1.42M	﹤0.01%	1266
2022 Q4	$47.3M	Buy	6,217,458 +12,484	+0.2%	+$104K	﹤0.01%	1274
2022 Q3	$50.7M	Sell	6,204,974 -7,570	-0.1%	-$69.5K	0.01%	1242
2022 Q2	$60.1M	Sell	6,212,544 -782,004	-11%	-$7.86M	0.01%	1182
2022 Q1	$98.1M	Buy	6,994,548 +18,661	+0.3%	+$259K	0.01%	1071
2021 Q4	$142M	Buy	6,975,887 +18,603	+0.3%	+$390K	0.01%	932
2021 Q3	$153M	Buy	6,957,284 +2,645,025	+61%	+$75.8M	0.01%	927
2021 Q2	$93.5M	Buy	+4,312,259	New	+$87.8M	0.01%	1144